1. 熟悉PDF編輯技巧(去水印、去章印、增刪內(nèi)容) 2. 處理完207個(gè)PDF上面的水印標(biāo)記和部分與文章標(biāo)題無(wú)關(guān)的內(nèi)容，提交后待成品效果符合要求后才判為合格，否則為不合格任務(wù)（具體處理細(xì)則可以QQ咨詢） 3. 需處理的PDF文檔待接下任務(wù)后再提供 4. 以前投過(guò)稿且完成效果較好的優(yōu)先考慮   [更多]

高價(jià)需求USP40   [更多]

文獻(xiàn)標(biāo)題： 1.The pathobiology of diabetic complications: a unifying mechanism. 2.Analysis of Risk Factors in Human Bioequivalence Study That Incur Bioinequivalence of Oral Drug Products. 3.A Berberine-Loaded Electrospun Poly-(ε-caprolactone) Nanofibrous Membrane with Hemostatic Potential and Antimicrobial Property for Wound Dressing. 4.China type 2 diabetes treatment status survey of treatment pattern of oral drugs users. J Diabetes. 2015 Mar;7(2):166-73 5.Non‐steroidal anti‐inflammatory drugs and upper gastrointestinal bleeding, a post‐marketing surveillance case‐control study 6.Individual nonsteroidal antiinflammatory drugs and other risk factors for upper gastrointestinal bleeding and perforation. 備注：將符合要求的文獻(xiàn)的PDF格式打包上傳   [更多]

1、藥材部分：以一個(gè)藥材為一列將pdf文檔內(nèi)容轉(zhuǎn)化為電子表格，電子表格的數(shù)據(jù)列有：藥材名，藥典品種，別名，商業(yè)藥材，非正品品種，性味歸經(jīng)，功能主治，等文檔中提到的部分。 中成藥部分：以一個(gè)中成藥為一列將pdf文檔內(nèi)容轉(zhuǎn)化為電子表格，電子表格的數(shù)據(jù)列有：處方，檢查，含量測(cè)定，方解，功能主治，注意事項(xiàng)，用法用量，貯藏，參考文獻(xiàn)等文檔中提到的部分。 2、 需處理的PDF文檔待接下任務(wù)后再提供 3、 以前投過(guò)稿且完成效果較好的優(yōu)先考慮   [更多]

標(biāo)題：重金求購(gòu)磷酸可待因《 EP9.4 》的藥典標(biāo)準(zhǔn)一份. Codeine phosphate sesquihydrate”《 EP9.4 》的藥典標(biāo)準(zhǔn)一份.   [更多]

求購(gòu)“Cyclohexylenedinitrilotetra-aceticacid.”最新的藥典標(biāo)準(zhǔn)一份.   [更多]

求購(gòu)“USP Monographs: Olopatadine Hydrochloride Ophthalmic Solution”美國(guó)最新藥典標(biāo)準(zhǔn)一份.   [更多]

標(biāo)題：重金求購(gòu)伐地那非BP2017標(biāo)準(zhǔn)一份 交稿方式：直接點(diǎn)擊交稿在線交稿就是了，我會(huì)每天過(guò)來(lái)看的，謝謝各位藥智的戰(zhàn)友們   [更多]

目前有766條超說(shuō)明書的內(nèi)容需要人工校對(duì)，已將數(shù)據(jù)分為11個(gè)數(shù)據(jù)包（RTF文件格式），每個(gè)數(shù)據(jù)包里包含了70個(gè)左右的藥品名，70元一個(gè)數(shù)據(jù)包，將最終結(jié)果填入我給的EXCEL表格內(nèi)。每人每次只可領(lǐng)取一個(gè)數(shù)據(jù)包，數(shù)據(jù)審核合格以后付款，完成優(yōu)秀者，可重復(fù)領(lǐng)取數(shù)據(jù)包。   [更多]

標(biāo)題： 1、Morisset M et al. Allergy to cow milk proteins contaminating lactose, common excipient of dry powder inhalers for asthma. J Allergy Clin Immunol 2006; 117(Suppl. 1): 95 2、Safety and tolerability of selumetinib as a monotherapy, or in combination with docetaxel as second-line therapy, in Japanese patients with advanced solid malignancies or non-small cell lung cancer. 3、Preparation and characterization of a cocrystalline suspension of [LysB28,ProB29]-human insulin analogue. DeFelippis MR1, Bakaysa DL, Bell MA, Heady MA, Li S, Pye S, Youngman KM, Radziuk J, Frank BH 1、Heterocycles, 2001 , vol. 55, # 2 p. 331 - 352 4、R. G. Strickley, L. Liu, and P. Lapresca. Preclinical parenteral and oral formulations of water insoluble molecules. ISSX Meet- ing, Nashville, TN (USA) Abstract # 291 (1999). (Z) 5、465: A possible genetic signature of DNA repair genes in triple negative breast cancers by a NGS approach 4、Systemic exposure to?atorvastatin?between Asian and Caucasian subjects: a combined analysis of 22 studies. 6、 Evaluation of cardiovascular morbidity associated with adherence to?atorvastatin?therapy. 7、Beta-lactam antibiotics: their role in the management of infections in children 8、China type 2 diabetes treatment status survey of treatment pattern of oral drugs users. J Diabetes. 2015 Mar;7(2):166-73 9、Non‐steroidal anti‐inflammatory drugs and upper gastrointestinal bleeding, a post‐marketing surveillance case‐control study 10、Individual nonsteroidal antiinflammatory drugs and other risk factors for upper gastrointestinal bleeding and perforation. 備注：將符合要求文獻(xiàn)的PDF格式打包上傳   [更多]